11.1 Information on toxicological effects
Acute toxicity
Acute toxicity estimate Oral - 5.1 mg/kg (Expert judgment)
Remarks: (Regulation (EC) No 1272/2008, Annex VI)
Acute toxicity estimate Inhalation - 0.051 mg/l - dust/mist (Expert judgment)
Remarks: (Regulation (EC) No 1272/2008, Annex VI)
Acute toxicity estimate Dermal - 50.1 mg/kg (Expert judgment)
Remarks: (Regulation (EC) No 1272/2008, Annex VI)
Skin corrosion/irritation
Classified based on available data. For more details, see section 2
Serious eye damage/eye irritation
Classified based on available data. For more details, see section 2
Respiratory or skin sensitization
Classified based on available data. For more details, see section 2
Germ cell mutagenicity
Classified based on available data. For more details, see section 2
Carcinogenicity
Suspected of causing cancer.
Reproductive toxicity
May damage the unborn child. Positive evidence from human epidemiological studies.
May damage fertility. Positive evidence from human epidemiological studies.
Studies indicating a hazard to babies during the lactation period
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Causes damage to organs through prolonged or repeated exposure.
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
RTECS: OW1225000
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated., In contrast to inorganic mercury compounds, alkyl mercury compounds rapidly pass through the placenta and blood brain barrier. The peripheral and central nervous systems and the kidney are major target organs. Methylmercury poisoning symptoms result primarily from damage to the nervous system. The symptoms are primarily characterized by loss of sensation in the hands and feet and in areas around the mouth, diminution of vision resulting in tunnel vision, ataxia, dysarthria, and hearing loss.
Severe poisoning produces blindness, coma and death. There is a latent period of weeks to months before development of the poisoning symptoms. Mercury shows a specificity to damage small nerve cells in the cerebellum and visual cortex. Methylmercury causes degeneration and necrosis of neurons in the focal areas of the cerebral cortex, especially within the visual areas of the occipital cortex and the granular layer of the cerebellum. It has been found that methylmercury inhibits protein synthesis in the brain before symptoms of poisoning appear and that recovery of protein synthesis does not occur in granular cells as it does recover in other neuronal cell types. Consumption by pregnant women has caused serious neurological disorders in their offspring resulting in mental retardation with cerebral palsy. Acute exposure to nonlethal levels of methylmercyry results in severely depressed lymphocyte response to T-cell mitogens thus depressing polyclonal activation of lymphocytes by T-cell mitogens and antibody responses to sepcific antigenic stimulation.